S&P 500
6,005.88
+0.1%
+$5.52
DJI
42,761.76
-0.0%
-$1.11
NASDAQ
19,591.24
+0.3%
+$61.28
Bitcoin
108,821.00
+2.5%
+2,608.12
AAPL
$201.70
-1.1%
-$2.22
AMZN
$217.31
+1.8%
+$3.74
GOOG
$177.80
+1.8%
+$3.09
META
$694.90
-0.4%
-$2.81
MSFT
$472.66
+0.5%
+$2.28
NVDA
$142.74
+0.7%
+$1.02
TSLA
$308.41
+4.5%
+$13.27
CRISPR Therapeutics (NASDAQ: CRSP)
$42.16
(0.7%)
$0.30
Price as of June 9, 2025, 3:58 p.m. ET
CRISPR Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
CRISPR Therapeutics Company Info
CRISPR Therapeutics is a biotech company using gene therapy to try to correct genetic mutations to treat and cure diseases.
News & Analysis
The Fool has written over 400 articles on CRISPR Therapeutics.
Featured Article
The 2 Smartest Beaten-Down Biotech Stocks to Buy on the Dip
Prosper Junior Bakiny | Jun 2, 2025
Featured Article
CRISPR Therapeutics Stock Could Double Your Money, According to Wall Street. Is It Time to Buy?
Cory Renauer | May 20, 2025
Prediction: This Beaten-Down Stock Could Double in The Next 5 Years
Prosper Junior Bakiny | May 18, 2025
Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics?
David Jagielski | May 14, 2025
2 Biotech Stocks That Are Screaming Buys in May
Adria Cimino | May 13, 2025
Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?
Justin Pope | May 12, 2025
The company has shown its revolutionary technology can deliver life-changing therapies. Now, it's about whether CRISPR Therapeutics can replicate the success across its promising pipeline.
3 Magnificent Stocks That Could Double or More by 2030
Keith Speights, David Jagielski, and Prosper Junior Bakiny | Apr 12, 2025
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
Adria Cimino | Apr 11, 2025
Valuation
Podcast Episodes
"The Era of the Gene-Edited Human Is Here"
An investor's look.
Chris Hill | Sep 19, 2022
Breaking Down CRISPR Technology
What investors need to know.
Karl Thiel | Sep 28, 2021
Is Amarin's Fish Oil Pill on Track to Become a Blockbuster?
Plus, how gene-editing company CRISPR Therapeutics just took a big step forward.
Todd Campbell | Nov 22, 2019
Did China’s “Designer Babies” Just Open Pandora’s Box?
What will this mean for healthcare and for the future of society?
Motley Fool Staff | Dec 21, 2018
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.